Cardiovascular Systems, Inc. CSII
Set alert
20.00 0.00 0.00%
At close · Apr 27
19.98 Day range 20.00
52-week range unavailable
- Open
- 19.99
- Prev close
- 20.00
- Mkt cap
- 843.96M
- Vol
- 387.78K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 19.98
- High
- 20.00
- Forward P/E
- -42.55
- Beta
- 0.74
- Short ratio
- 2.66
- Inst. own
- 89.65%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 3, 2023
- 50-d avg
- 19.84
- 200-d avg
- 15.84
- 1y target
- 17.33
Analyst view
Consensus: hold
Hold
Price target (mean) 17.33 -13.4% downside
Now 20.00
- Target (low)
- 14.00
- Target (mean)
- 17.33
- Target (high)
- 20.00
Ratings (0m) 7 5 buy · 1 hold · 1 sell
- Strong buy2
- Buy3
- Hold1
- Sell1
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
- 2 months ago 7
- 3 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.12 | -0.13 – -0.11 | -0.25 | +52.0% | 63.66M | +13.2% | 2 |
| Next quarter | -0.11 | -0.12 – -0.10 | -0.25 | +56.0% | 70.19M | +12.3% | 2 |
| Current year | -0.67 | -0.68 – -0.66 | -0.94 | +28.7% | 255.57M | +8.2% | 2 |
| Next year | -0.47 | -0.51 – -0.42 | -0.67 | +29.9% | 279.77M | +9.5% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 21, 2022 | Barclays | Initiated | — | Equal-Weight |
| May 5, 2022 | SVB Leerink | Maintained | — | Outperform |
| Feb 4, 2022 | SVB Leerink | Maintained | — | Outperform |
| Nov 17, 2021 | Needham | Downgrade | Buy | Hold |
| Nov 10, 2021 | Guggenheim | Downgrade | Buy | Neutral |
| Nov 10, 2021 | SVB Leerink | Maintained | — | Outperform |
| Sep 23, 2021 | Needham | Maintained | — | Buy |
| May 25, 2021 | Barclays | Initiated | — | Equal-Weight |
| Feb 4, 2021 | Needham | Maintained | — | Buy |
| Dec 14, 2020 | SVB Leerink | Maintained | — | Outperform |
| Nov 5, 2020 | Needham | Maintained | — | Buy |
| Aug 12, 2020 | Aegis Capital | Maintained | — | Buy |
| Aug 5, 2020 | SVB Leerink | Maintained | — | Outperform |
| Jul 22, 2020 | Northland Capital Markets | Initiated | — | Outperform |
| Jun 19, 2020 | Aegis Capital | Initiated | — | Buy |
| Jun 11, 2020 | Needham | Upgrade | Hold | Buy |
| Apr 7, 2020 | Oppenheimer | Initiated | — | Outperform |
| Oct 18, 2019 | Guggenheim | Initiated | — | Buy |
| Jul 17, 2019 | Stifel Nicolaus | Downgrade | Buy | Hold |
| Aug 22, 2018 | Stifel Nicolaus | Initiated | — | Buy |
| Feb 8, 2018 | Leerink Swann | Maintained | Outperform | Outperform |
| Dec 19, 2017 | Needham | Downgrade | Buy | Hold |
| Sep 22, 2017 | Raymond James | Initiated | — | Market Perform |
| Jun 21, 2017 | Bank of America | Downgrade | Neutral | Underperform |
| Aug 22, 2016 | Leerink Swann | Upgrade | Market Perform | Outperform |
| Aug 4, 2016 | Bank of America | Upgrade | Underperform | Neutral |
| Apr 1, 2016 | Needham | Upgrade | Hold | Buy |
| Jan 22, 2016 | Needham | Downgrade | — | Underperform |
| Oct 8, 2015 | Leerink Swann | Downgrade | Outperform | Market Perform |
| Oct 8, 2015 | Bank of America | Downgrade | Neutral | Underperform |